Welcome to MyIDSA, IDSA’s Member-Only Community! Connect with Colleagues, Share Resources, Start or Join a Lively Discussion. Join us…It’s Infectious!
JOIN THE DISCUSSION
Colleagues, Curious what others--and notably our ID pharmacists--are advising high risk COVID-19 patients who are nirmatrelvir/ritonavir candidates but on apixaban or rivaroxaban for DVT/PE or Atrial Fibrillation indication. Let's assume no access to ...
The AHRQ also has a nice ressource on this: https://www.ahrq.gov/antibiotic-use/acute-care/safety/communication.html ------------------------------ Elie Saade MD;MPH Physician University Hospitals Cleveland Medical Center Cleveland OH --------- ...
The Grants for Emerging Researchers/Clinicians Mentorship Program is recruiting medical students with interest in career paths in ID and HIV to apply for the program. Awardees will receive a $4,000 stipend to complete their project and be paired ...
Read More
The COVID-19 Real-Time Learning Network is a curated repository of clinical guidance, emerging research, and practice management tools to support clinicians of all backgrounds. With funding from the Centers for Disease Control and Prevention and guidance from a multidisciplinary Advisory Group, this site is updated daily with must-have information for clinicians and decision-makers.
Either the content you're seeking doesn't exist or it requires proper authentication before viewing.
Help attract the best and brightest to the field of infectious diseases.
Infectious Diseases Society of America